NEUROSENSE THERAPEUTICS
NeuroSense Therapeutics Ltd., is a clinical-stage biotechnology company, dedicated to the discovery and development of treatments for debilitating neurodegenerative diseases. Its lead product, PrimeC, is a novel oral therapy for the treatment of amyotrophic lateral sclerosis (ALS). The company's preclinical pipeline includes: (1) StabiliC for the treatment of Parkinson's disease and (2) CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.
NEUROSENSE THERAPEUTICS
Industry:
Biotechnology Neuroscience
Founded:
2017-01-01
Address:
Herzliya, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.neurosense-tx.com
Total Employee:
11+
Status:
Active
Contact:
+972-9-9531142
Email Addresses:
[email protected]
Total Funding:
529 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
PipelBiz.com
PipelBiz.com investment in Equity Crowdfunding - NeuroSense Therapeutics
Official Site Inspections
http://www.neurosense-tx.com Semrush global rank: 6.69 M Semrush visits lastest month: 874
- Host name: webnoise1.spd.co.il
- IP address: 192.116.109.25
- Location: Tel Aviv Israel
- Latitude: 32.0678
- Longitude: 34.7647
- Timezone: Asia/Jerusalem
